Kasus nalaria vivaks resisten terhadap klorokuin dan ualaria vivalts pasca transfusi yang resisten terhadap klorokuin dan kina telah dilaporkan di Indonesia. Oleh 
INTRODUCTION
Plasmodium vivax and P. falciparum are the most common species of malaria parasites in Indonesia.
Even though most of the studies were focussed mainly on P-falciparum because of the relevance of that species to human life, on the contrary, P. vivax infection which is generally considered to be benign, could also decrease daily working activities and productivity.
At present, chloroquine is still the drug of choice for malaria lreatment 
Follow-up
The patiens were followed up to D28. On discharge, they were given multivitamins and insecticide-impregnated bed nets. Subjects were instructed not to take other antimalarials during the study and to immediately report to the hospital if they became sick. They were also instructed to sleep under mosquito net. The most frequent ( t 5O 7o) clinical symptoms and signs in both groups were fever, headache, nausea and chills. However, there were no significant difference between the two groups ( Table 2) .
Comparative laboratory test results between trealment groups.
Results of routine haematology and biochemistry examinations showed within normal values on admission (pre-treatment). However, the platelet counts were low (< 150/nl) and total bilirubin were slightly high ( > 1.1 mg%) in both groups. Further analysis showed a significant difference for the alkaline phosphatase (Table   3 ). The results of all laboratory tests from both groups were within normal values on discharge from the hospital (post-treatment). However, the two groups showed significant differences in the white cell counts, SGOT/ASAT, SGPT/ALAT, alkaline phosphatase and BUN (Table 4) . There was evidence of only mild intolerance of chloroquine and halofantrine which proved self-limiting and resolved rapidly without intervention. However, there was no significant difference between both groups. Laboratory findings showed no evidence of toxicity by chloroquine-primaquine and halofantrineprimaquine either haematologically or biochemically.
Our previous study of halofantrine alone in uncomplicated falciparum malaria had similar clinical side effects as compared to the other studiess-9 CONCLUSION Chloroquine-primaquine was very effective against P. vivax in Tomohon, North Sulawesi, Halofantrineprimaquine also gave a good therapeutic response and was safe. On the basis of preliminary evidence reported elsewhere,2l'22 the efficacy of cirloroquine in this study may be dependent upon the administration of primaquine.
